SCHEMBL6949464

SCHEMBL6949464

N#Cc1ccccc1N1CCc2ccccc2CC1

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.46
SLC22A12 Q96S37 2/20 0.46
TAS1R3 Q7RTX0 1/20 0.46
TAS1R1 Q7RTX1 1/20 0.46
TAS1R2 Q8TE23 1/20 0.46
DRD4 P21917 4/20 0.45
DRD2 P14416 4/20 0.45
DRD3 P35462 2/20 0.45
GRM5 P41594 1/20 0.44
NAMPT P43490 1/20 0.44
MAOA P21397 2/20 0.44
MAOB P27338 2/20 0.44
DRD1 P21728 1/20 0.44
DRD5 P21918 1/20 0.44
ALDH1A1 P00352 1/20 0.43
MAPT P10636 1/20 0.43
MAPK1 P28482 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
NOTUM Q6P988 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL703104 0.91 MAPT (0.52) TAS1R3TAS1R1TAS1R2NAMPTMAOA
SCHEMBL29978097 0.91 MAPT (0.52) TAS1R3TAS1R1TAS1R2NAMPTMAOA
SCHEMBL3088832 0.86 DRD4 (0.54) ARDRD4DRD2DRD3GRM5
SCHEMBL7716739 0.83 DRD4 (0.47) ARDRD4DRD2DRD3GRM5
SCHEMBL829177 0.82 AR (0.65) ARDRD4DRD2GRM5ALDH1A1
SCHEMBL30406641 0.82 AR (0.59) ARDRD4DRD2DRD3GRM5
SCHEMBL10623786 0.81 SLC22A12 (0.47) SLC22A12TAS1R3TAS1R1TAS1R2DRD4
SCHEMBL2077261 0.81 ADRA2C (0.56) ARDRD4DRD2DRD3GRM5
SCHEMBL21572676 0.81 DRD4 (0.48) ARDRD4DRD2DRD3GRM5
SCHEMBL12632974 0.81 GRM2 (0.50) TAS1R3TAS1R1TAS1R2MAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed